Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Return on Assets (2016 - 2025)

Historic Return on Assets for Seres Therapeutics (MCRB) over the last 11 years, with Q2 2025 value amounting to 0.91%.

  • Seres Therapeutics' Return on Assets rose 9900.0% to 0.91% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.91%, marking a year-over-year increase of 9900.0%. This contributed to the annual value of 0.51% for FY2024, which is 2900.0% up from last year.
  • Seres Therapeutics' Return on Assets amounted to 0.91% in Q2 2025, which was up 9900.0% from 0.88% recorded in Q1 2025.
  • Seres Therapeutics' Return on Assets' 5-year high stood at 0.91% during Q2 2025, with a 5-year trough of 0.79% in Q3 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.14% (2023), whereas its average is 0.06%.
  • In the last 5 years, Seres Therapeutics' Return on Assets tumbled by -6900bps in 2022 and then soared by 9900bps in 2025.
  • Quarter analysis of 5 years shows Seres Therapeutics' Return on Assets stood at 0.17% in 2021, then crashed by -222bps to 0.55% in 2022, then skyrocketed by 82bps to 0.1% in 2023, then surged by 880bps to 0.79% in 2024, then rose by 15bps to 0.91% in 2025.
  • Its last three reported values are 0.91% in Q2 2025, 0.88% for Q1 2025, and 0.79% during Q4 2024.